Navigation Links
Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013
Date:6/13/2013

Boston, Ma (PRWEB) June 13, 2013

Cambridge Semantics will be a featured presenter at DIA 2013 taking place June 23rd through the 27th in Boston. As part of the Innovation Theater track, Cambridge Semantics will showcase how technology innovations made possible by semantics can help pharmaceutical companies improve drug safety and bolster business development while minimizing risk.

The most important data-related challenge facing pharma today is the ability to use data to make critical business decisions. Most of these decisions don’t need Big Data: they simply need the right data at the right time. Semantic Web standards enable pharmaceutical organizations to make data smarter by offering greater data access and data understanding, allowing them to more effectively mitigate risk across the drug development and commercialization spectrum.

Session information
Tuesday, June 25th at Noon EDT
Title: “How Can Technology Change the Way Pharmas Handle Risk? Innovations in Drug Safety and Business Development
Location: Exhibit Hall

Based on Semantic Web technologies, the award-winning Anzo Pharma Competitive Intelligence Solution from Cambridge Semantics is currently in use at some of the world’s top biopharma organizations. R&D teams, business development, marketing and knowledge management groups leverage Anzo to easily route targeted information to the right people at the right time from the right sources, incorporating both structured and unstructured data. As a result, pharmaceutical organizations can harmonize information more rapidly and make better business decisions.

To learn more about Cambridge Semantics and the award winning Anzo Pharma Competitive Intelligence Solution please visit http://www.cambridgesemantics.com.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10826188.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
2. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
3. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
4. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
5. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
6. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
7. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
8. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
9. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
10. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
11. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):